David Garner
David Garner is Chief Business Officer at Dopl Technologies. He is self-employed as Co-Founder and Head of Operations at Venture Black and CEO and Founder at RhinoCeros. He was Co-Founder, Chief Operations Officer and Chief Marketing Officer at CalmWave®, Chief Executive Officer at Vave Health, and Vice President Commercial at Butterfly Network, Inc. He was Global Director of Marketing and Product Management, Product Director, Imaging Solutions at Verathon Inc., subsidiary of Roper Industries. He was an Investor at Seattle Angel Conference and Board Advisor at Kool Nerd Club.
Wink Therapeutics Wins Seattle Pitch Event, Gains $50K-$100K Investment for RNA-Based Type 1 Diabetes Therapy
Wink Therapeutics, a Miami-based RNA biotech startup focused on Type 1 diabetes, won first place and $50,000-$100,000 investment at a Seattle pitch event hosted by Venture Black. The company uses RNA therapeutics to restore pancreatic beta cells and was founded by biotech veteran Warren Marcus.
Seattle Startup CalmWave Raises $4M to Reduce ICU Alarm Fatigue, Backed by AI2 Incubator and Bonfire Ventures
CalmWave, a new Seattle startup spun out from the AI2 Incubator, raised $4 million to reduce excessive ICU alarms that cause nurse fatigue and patient harm. Founded by Ophir Ronen, the company aims to address the problem of alarm fatigue by lowering false and clinically insignificant alarms in hospital settings.
Organizations
See all 13-
Dopl Technologies Chief Business Officer 2024–present · current
-
Venture Black Co-Founder and Operations Director 2024–present, Operations Director · current
-
RhinoCeros CEO, Founder 2017–present · current
Education
-
Carnegie Mellon University Bachelor of Science (B.S.), Mechanical Engineering, Engineering Design
-
MIT Sloan School of Management Management & Engineering
-
Milton
-
Carnegie Mellon University Bachelor of Science - BS, Mechanical Engineering